What is the Kitazato Corporation stock price forecast?

Kitazato Corporation is currently trading at ¥1,166. View real-time AI analysis on Alpha Lenz.

What is Kitazato Corporation insider trading activity?

View the latest insider trading data for Kitazato Corporation on Alpha Lenz.

What is Kitazato Corporation's P/E ratio?

Kitazato Corporation's P/E ratio is 12.3.

Kitazato Corporation

JPX · 368A

¥1,166-12(-1.02%)Market closed

Ask about Kitazato Corporation's future dividend policy...

Alpha Chat Insight

“Kitazato Corporation trades at a P/E of 12.3 (undervalued) with strong ROE of 22.1%. Operating margin of 56.1% indicates strong profitability.”

Ask for details →

Company Overview

Kitazato Corporation is a Japanese manufacturer specializing in medical devices and related products for fertility treatment and assisted reproduction. Founded in 2007 and rooted in a tradition of scientific innovation, the company conducts research, development, and global distribution of equipment and consumables used in a range of reproductive technologies, including in-vitro fertilization (IVF), intrauterine insemination (IUI), and preimplantation genetic testing (PGT). Kitazato Corporation emphasizes quality and cutting-edge advancements in the field of assisted reproductive technologies, supporting clinics and laboratories around the world with certified products and technical expertise. Its operations play a significant role in the precision instruments sector, addressing the growing demand for fertility solutions in both domestic and international markets. The company's commitment to research, environmental responsibility, and patient-centered product development positions it as a key contributor to medical device innovation, particularly within the fertility and biotechnology industries.

CEOMr. Futoshi Inoue M.B.A., Ph.D., Pharm.D.

Websitehttps://www.kitazato.co.jp

SectorHealthcare

IndustryMedical Instruments & Supplies

Employees86

Company Statistics

FY 2025

Profile

¥46,640,000,000Market Cap

¥10,302,000,000Revenue

0.00Shares Out

86Employees

Margins

67.70%Gross

57.84%EBITDA

56.13%Operating

55.73%Pre-Tax

36.78%Net

Valuation

12.31P/E

2.56P/B

4.53EV/Sales

5.90EV/EBITDA

17.78P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

20.15%ROA

22.09%ROE

30.54%ROIC

Financial Health

¥11,460,000,000Cash & Cash Equivalents

¥-9,961,000,000Net Debt

8.21%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Kitazato Corporation trades at a P/E of 12.3 (undervalued) with strong ROE of 22.1%. Operating margin of 56.1% indicates strong profitability.”

Ask for details →

Frequently Asked Questions

Kitazato Corporation (ticker: 368A) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 86 employees. Market cap is $46.6B.

The current price is 1,166 with a P/E ratio of 12.31x and P/B of 2.56x.

ROE is 22.09% and operating margin is 56.13%. Annual revenue is $10.3B.